<?xml version="1.0"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN">
  <?properties open_access?>
  <?properties no_embargo?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Synapse</journal-id>
      <journal-id journal-id-type="publisher-id">syn</journal-id>
      <journal-title>Synapse (New York, N.y.)</journal-title>
      <issn pub-type="ppub">0887-4476</issn>
      <issn pub-type="epub">1098-2396</issn>
      <publisher>
        <publisher-name>Wiley Subscription Services, Inc., A Wiley Company</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">2673354</article-id>
      <article-id pub-id-type="pmid">18720515</article-id>
      <article-id pub-id-type="doi">10.1002/syn.20553</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Altered hippocampal expression of glutamate receptors and transporters in GRM2 and GRM3 knockout mice</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Lyon</surname>
            <given-names>Louisa</given-names>
          </name>
          <xref ref-type="aff" rid="au1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kew</surname>
            <given-names>James NC</given-names>
          </name>
          <xref ref-type="aff" rid="au2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Corti</surname>
            <given-names>Corrado</given-names>
          </name>
          <xref ref-type="aff" rid="au3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Harrison</surname>
            <given-names>Paul J</given-names>
          </name>
          <xref ref-type="aff" rid="au1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Burnet</surname>
            <given-names>Philip WJ</given-names>
          </name>
          <xref ref-type="aff" rid="au1">1</xref>
          <xref ref-type="corresp" rid="cor1">*</xref>
        </contrib>
      </contrib-group>
      <aff id="au1">
        <label>1</label>
        <institution>Department of Psychiatry, University of Oxford, Warneford Hospital</institution>
        <addr-line>Oxford OX3 7JX, United Kingdom</addr-line>
      </aff>
      <aff id="au2">
        <label>2</label>
        <institution>Psychiatry DTG, GlaxoSmithKline, New Frontiers Science Park</institution>
        <addr-line>Third Avenue, Harlow, Essex CM195AW, United Kingdom</addr-line>
      </aff>
      <aff id="au3">
        <label>3</label>
        <institution>Psychiatry Centre of Excellence for Drug Discovery, GlaxoSmithKline</institution>
        <addr-line>Via Fleming 4, Verona, Italy</addr-line>
      </aff>
      <author-notes>
        <corresp id="cor1">* Correspondence to: Philip W.J. Burnet, Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford OX3 7JX, United Kingdom. E-mail: <email>phil.burnet@psych.ox.ac.uk</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>11</month>
        <year>2008</year>
      </pub-date>
      <volume>62</volume>
      <issue>11</issue>
      <fpage>842</fpage>
      <lpage>850</lpage>
      <history>
        <date date-type="received">
          <day>01</day>
          <month>2</month>
          <year>2008</year>
        </date>
        <date date-type="rev-recd">
          <day>28</day>
          <month>3</month>
          <year>2008</year>
        </date>
        <date date-type="accepted">
          <day>08</day>
          <month>4</month>
          <year>2008</year>
        </date>
      </history>
      <copyright-statement>Copyright &#xA9; 2008 Wiley-Liss, Inc., A Wiley Company</copyright-statement>
      <copyright-year>2008</copyright-year>
      <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.5/">
        <p>Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation.</p>
      </license>
      <abstract>
        <p>Group II metabotropic glutamate receptors (mGluR2 and mGluR3, also called mGlu2 and mGlu3, encoded by <italic>GRM2</italic> and <italic>GRM3</italic>, respectively) are therapeutic targets for several psychiatric disorders. <italic>GRM3</italic> may also be a schizophrenia susceptibility gene. mGluR2<sup>&#x2212;/&#x2212;</sup> and mGluR3<sup>&#x2212;/&#x2212;</sup> mice provide the only unequivocal means to differentiate between these receptors, yet interpretation of in vivo findings may be complicated by secondary effects on expression of other genes. To address this issue, we examined the expression of NMDA receptor subunits (NR1, NR2A, NR2B) and glutamate transporters (EAAT1-3), as well as the remaining group II mGluR, in the hippocampus of mGluR2<sup>&#x2212;/&#x2212;</sup> and mGluR3<sup>&#x2212;/&#x2212;</sup> mice, compared with wild-type controls. mGluR2 mRNA was increased in mGluR3<sup>&#x2212;/&#x2212;</sup> mice, and vice versa. NR2A mRNA was increased in both knockout mice. EAAT1 (GLAST) mRNA and protein, and EAAT2 (GLT-1) protein, were reduced in mGluR3<sup>&#x2212;/&#x2212;</sup> mice, whereas EAAT3 (EAAC1) mRNA was decreased in mGluR2<sup>&#x2212;/&#x2212;</sup> mice. Transcripts for NR1 and NR2B were unchanged. The findings show a compensatory upregulation of the remaining group II metabotropic glutamate receptor in the knockout mice. Upregulation of NR2A expression suggests modified NMDA receptor signaling in mGluR2<sup>&#x2212;/&#x2212;</sup> and mGluR3<sup>&#x2212;/&#x2212;</sup> mice, and downregulation of glutamate transporter expression suggests a response to altered synaptic glutamate levels. The results show a mutual interplay between mGluR2 and mGluR3, and also provide a context in which to interpret behavioral and electrophysiological results in these mice.</p>
      </abstract>
      <kwd-group>
        <kwd>group II metabotropic glutamate receptor</kwd>
        <kwd>mGlu2</kwd>
        <kwd>mGlu3</kwd>
        <kwd>hippocampus</kwd>
        <kwd>mRNA</kwd>
        <kwd>NMDA receptor</kwd>
        <kwd>glutamate transporter</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>INTRODUCTION</title>
      <p>Group II metabotropic glutamate receptors comprise mGluR2 (mGlu2, encoded by <italic>GRM2</italic>) and mGluR3 (mGlu3, encoded by <italic>GRM3</italic>). Both are G&#x2013;protein coupled receptors, whose activation inhibits adenylate cyclase and decreases cAMP formation. Their primary functions are thought to be as inhibitory autoreceptors and thence modulation of glutamatergic signaling (<xref ref-type="bibr" rid="b1">Anwyl, 1999</xref>; <xref ref-type="bibr" rid="b3">Cartmell and Schoepp, 2000</xref>); they also act as heteroceptors modulating the release of other transmitters including dopamine and GABA. There is considerable psychiatric interest in these receptors, for two main reasons. First, they are therapeutic targets for several disorders (<xref ref-type="bibr" rid="b18">Harrison, 2008</xref>; <xref ref-type="bibr" rid="b32">Moghaddam, 2004</xref>; <xref ref-type="bibr" rid="b47">Swanson et al., 2005</xref>), with recent clinical trials showing positive results in schizophrenia (<xref ref-type="bibr" rid="b39">&gt;Patil et al., 2007</xref>) and in generalized anxiety disorders (<xref ref-type="bibr" rid="b10">Dunayevich et al., 2007</xref>). Second, mGluR3 is a putative candidate gene for schizophrenia and is implicated in its pathophysiology (<xref ref-type="bibr" rid="b7">Corti et al., 2007a</xref>; <xref ref-type="bibr" rid="b12">Egan et al., 2004</xref>; <xref ref-type="bibr" rid="b20">Harrison et al., in press</xref>; <xref ref-type="bibr" rid="b42">Sartorius et al., 2008</xref>; <xref ref-type="bibr" rid="b50">Tan et al., 2007</xref>) as part of a broader glutamatergic dysfunction (<xref ref-type="bibr" rid="b19">Harrison and Weinberger, 2005</xref>; <xref ref-type="bibr" rid="b24">Konradi and Heckers, 2003</xref>).</p>
      <p>Given these findings, it becomes important to distinguish the properties of mGluR2 from those of mGluR3, a distinction that has been hampered by the lack of adequately selective ligands and antibodies. Nevertheless, several differences are known (for review, see <xref ref-type="bibr" rid="b20">Harrison et al., in press</xref>), including cellular and subcellular localization (<xref ref-type="bibr" rid="b49">Tamaru et al., 2001</xref>), expression profile across brain development (<xref ref-type="bibr" rid="b5">Catania et al., 1994</xref>), the presence of splice variants (<xref ref-type="bibr" rid="b41">Sartorius et al., 2006</xref>), and interactions with protein phosphatase 2C (<xref ref-type="bibr" rid="b13">Flajolet et al., 2003</xref>). These findings are complemented recently by data in mGluR2<sup>&#x2212;/&#x2212;</sup> and mGluR3<sup>&#x2212;/&#x2212;</sup> mice. For example, mGluR2<sup>&#x2212;/&#x2212;</sup> mice show reduced mossy fiber long&#x2013;term depression (<xref ref-type="bibr" rid="b54">Yokoi et al., 1996</xref>) and locomotor hyperactivity (<xref ref-type="bibr" rid="b36">Morishima et al., 2005</xref>), whereas mGluR3<sup>&#x2212;/&#x2212;</sup> mice show enhanced hippocampal c&#x2013;Fos expression (<xref ref-type="bibr" rid="b26">Linden et al., 2006</xref>) and vulnerability to NMDA&#x2013;induced neurotoxicity (<xref ref-type="bibr" rid="b8">Corti et al., 2007b</xref>). However, conclusions drawn from knockout mice may be complicated by secondary changes in expression of other genes, which may compensate for, enhance, or otherwise modify, the effect of the gene deletion. Currently, the molecular phenotypes of mGluR2<sup>&#x2212;/&#x2212;</sup> and mGluR3<sup>&#x2212;/&#x2212;</sup> mice remain unknown. This study has therefore examined the expression of key genes involved in glutamatergic neurotransmission in both knockout mice compared with their respective wild&#x2013;type littermates. We focused on the hippocampus, as a structure critically involved in schizophrenia (<xref ref-type="bibr" rid="b17">Harrison, 2004</xref>) and cognition (<xref ref-type="bibr" rid="b31">Martin and Clark, 2007</xref>; <xref ref-type="bibr" rid="b48">Sweatt, 2004</xref>), and in which mGluR function has previously been examined in detail. The targeted genes included the remaining group II mGluR, to assess the possibility of compensatory upregulation, as well as NMDA receptors (NR1, NR2A, NR2B subunits) and glutamate transporters (EAAT1 [GLAST], EAAT2 [GLT&#x2013;1], and EAAT3 [EAAC1]). These receptors and transporters were measured because there is already pharmacological evidence linking them with mGluR2 and/or mGluR3 (e.g., <xref ref-type="bibr" rid="b2">Aronica et al., 2003</xref>; <xref ref-type="bibr" rid="b4">Cartmell et al., 1999</xref>; <xref ref-type="bibr" rid="b16">Gegelashvili et al., 2000</xref>; <xref ref-type="bibr" rid="b25">Krystal et al., 2005</xref>; <xref ref-type="bibr" rid="b33">Moghaddam and Adams, 1998</xref>), and we predicted a change in their expression as a correlate of the altered glutamate signaling characteristics that likely accompany the genetic deletion of a group II mGluR. In each case, quantification of the encoding mRNA by in situ hybridization was used; in the case of EAAT1 and EAAT2 we complemented these results with immunoautoradiographic assessment of the protein. Our results show that deletion of mGluR2 or mGluR3 produces similar but not identical effects on expression of these glutamatergic genes, and illustrate the importance of both group II mGluRs in hippocampal glutamate signaling and thence, presumably, in hippocampal functioning. Some of the data have been presented in abstracts (<xref ref-type="bibr" rid="b29">Lyon et al., 2006</xref>, <xref ref-type="bibr" rid="b30">2007</xref>).</p>
    </sec>
    <sec sec-type="materials|methods">
      <title>MATERIALS AND METHODS</title>
      <sec>
        <title>Animals and tissue sectioning</title>
        <p>mGluR2<sup>&#x2212;/&#x2212;</sup> and mGluR3<sup>&#x2212;/&#x2212;</sup> mice were generated on a C57Bl/6 &#xD7; 129SVj background, as described (<xref ref-type="bibr" rid="b6">Corti et al., 2004</xref>, <xref ref-type="bibr" rid="b7">2007a</xref>; <xref ref-type="bibr" rid="b54">Yokoi et al., 1996</xref>). Brains from six male 12&#x2013;week&#x2013;old mGluR2<sup>&#x2212;/&#x2212;</sup> mice and six wild&#x2013;type littermates, plus six male 12&#x2013;week&#x2013;old mGluR3<sup>&#x2212;/&#x2212;</sup> mice and six wild&#x2013;type littermates, were snap frozen by immersion in chilled isopentane. Brains were stored at &#x2212;80&#xB0;C. Unfixed coronal sections (12 &#x3BC;m) containing the dorsal hippocampus were collected on a Shandon cryostat at &#x2212;20&#xB0;C. Sections were collected on Superfrost Plus slides (VWR, Lutterworth, UK), three per slide, and stored at &#x2212;70&#xB0;C.</p>
      </sec>
      <sec>
        <title>In situ hybridization histochemistry</title>
        <p>In situ hybridization histochemistry was carried out as described by <xref ref-type="bibr" rid="b11">Eastwood et al. (2007)</xref>. Pretreatment consisted of: freshly prepared 4% paraformaldehyde in phosphate&#x2013;buffered saline (PBS) (5 min); (PBS rinse); 0.1 M triethanolamine&#x2013;NaCl solution containing 0.25% acetic anhydride added immediately prior to use (10 min); 70% ethanol (1 min); 80% ethanol (1 min); 95% ethanol (2 min); 100% ethanol (1 min); chloroform (10 min); 100% ethanol (1 min); 95% ethanol (1 min). Sections were air7&#x2013;dried and stored at &#x2212;20&#xB0;C. Oligonucleotide probes were synthesized (Sigma, Dorset, UK) (<xref ref-type="table" rid="tbl1">Table I</xref>) and 3&#x2032; end&#x2013;labeled with [<sup>35</sup>S]dATP using the enzyme terminal deoxynucleotidyl transferase (TdT) (Promega, Southampton, UK). Labeled probe was purified from unincorporated nucleotides using Nick Columns (Amersham, Bucks, UK) according to manufacturer's instructions. Sections were incubated overnight at 35&#xB0;C in 225 &#x3BC;l hybridization buffer [4&#xD7; sodium saline citrate (SSC), 50% deionized formamide, 10% dextran sulfate, 25 mM sodium phosphate (pH 7.0), 5&#xD7; Denhardt's solution, 200 &#x3BC;g/ml salmon sperm DNA, 100 &#x3BC;g/ml poly(A), 1 mM sodium pyrophosphate, 120 &#x3BC;g/ml heparin] containing 3&#xD7; 10<sup>6</sup> counts per minute of labeled probe and 20 &#x3BC;M dithiothreitol. Posthybridization washes were conducted in 1&#xD7; SSC for 3&#xD7; 20 min at 55&#xB0;C, followed by 2&#xD7; 60 min at room temperature. Hybridized sections were apposed to Kodak Biomax MS film together with <sup>14</sup>C microscales (GE Healthcare, Little Chalfont, UK) for an optimal length of time determined by trial experiments (<xref ref-type="table" rid="tbl1">Table I</xref>).</p>
        <table-wrap id="tbl1" position="float">
          <label>TABLE 1</label>
          <caption>
            <p>Nucleotide sequences of probes used for in situ hybridization histochemistry, and exposure times against autoradiographic film</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th align="center" rowspan="1" colspan="1">Gene</th>
                <th align="center" rowspan="1" colspan="1">GenBank accesssion number</th>
                <th align="center" rowspan="1" colspan="1">Oligodeoxynucleotide sequence (5&#x2032; to 3&#x2032;)</th>
                <th align="center" rowspan="1" colspan="1">Exposure time(days)</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" rowspan="1" colspan="1">mGluR2</td>
                <td align="center" rowspan="1" colspan="1">XM_001475814.1</td>
                <td align="left" rowspan="1" colspan="1">GGT GAA GAG CAC AGC CAC ACG GGC GCT GGG CTT CT</td>
                <td align="center" rowspan="1" colspan="1">12</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">mGluR3</td>
                <td align="left" rowspan="1" colspan="1">NM_181850.2</td>
                <td align="left" rowspan="1" colspan="1">TTG CCA CCT GTA TGG AAA CAC TGC TGT ACG AAC CC</td>
                <td align="left" rowspan="1" colspan="1">21</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">EAAT1</td>
                <td align="left" rowspan="1" colspan="1">NM_148938.2</td>
                <td align="left" rowspan="1" colspan="1">GTA GTA GTC ATG TAA TAG ACT ACA GCG CGC ATC CCC</td>
                <td align="left" rowspan="1" colspan="1">12</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">EAAT2</td>
                <td align="left" rowspan="1" colspan="1">NM_011393.2</td>
                <td align="left" rowspan="1" colspan="1">GTA CCT TGC ACT CAT CTA TTA CGA CAG AGT TGT GT</td>
                <td align="left" rowspan="1" colspan="1">5</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">EAAT3</td>
                <td align="left" rowspan="1" colspan="1">NM_009199.2</td>
                <td align="left" rowspan="1" colspan="1">TAG TGA GTT CCA GGA TAT CCA GGG CTA TGT AGA GA</td>
                <td align="left" rowspan="1" colspan="1">4</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">NR1</td>
                <td align="left" rowspan="1" colspan="1">NM_008169</td>
                <td align="left" rowspan="1" colspan="1">GTA GAC CTG GCT GGA GAT GAG GTC CTC GCA CAC CGA CAG AGC CAT</td>
                <td align="left" rowspan="1" colspan="1">4</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">NR2A</td>
                <td align="left" rowspan="1" colspan="1">NM_008170</td>
                <td align="left" rowspan="1" colspan="1">AGA AGG CCC GTG GGA GCT TTC CCT TTG GCT AAG TTTC</td>
                <td align="left" rowspan="1" colspan="1">4</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">NR2B</td>
                <td align="left" rowspan="1" colspan="1">NM_008171.3</td>
                <td align="left" rowspan="1" colspan="1">GGG CCT CCT GGC TCT CTG CCA TCG GCT AGG CAC CTG TTG TAA CCC</td>
                <td align="left" rowspan="1" colspan="1">8</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
      </sec>
      <sec>
        <title>Immunoautoradiography</title>
        <p>Sections were fixed in 4% paraformaldehyde/PBS for 5 min, and then washed twice in PBS. Nonspecific binding was blocked by incubating the slides in 200 &#x3BC;l of normal donkey serum (Sigma, Dorset, UK), diluted 1:10 in PBS with 0.3% Triton X&#x2013;100 (PBS&#x2013;T), for 30 min at room temperature. Sections were incubated overnight at 4&#xB0;C with rabbit polyclonal anti&#x2013;EAAT1 (Abcam, Cambridge, UK) diluted 1:200 in PBS&#x2013;T, or with rabbit polyclonal anti-EAAT2 (Abcam) diluted 1:200 with PBS&#x2013;T. Omission of primary antibody was used as a control. After three PBS washes to remove unbound primary, sections were incubated with 0.2 &#x3BC;Ci/ml [<sup>35</sup>S]&#x2013;labeled donkey antirabbit IgG (Amersham) at 1:500 in PBS&#x2013;T and 1% donkey serum, for 1 h at room temperature. Following washes in PBS and MilliQ Ultrapure water to remove unbound secondary, slides were left to air&#x2013;dry, before being placed against Kodak Biomax MS film with <sup>14</sup>C microscales for 7 days.</p>
      </sec>
      <sec>
        <title>Image and statistical analysis</title>
        <p>Autoradiographic films were developed under safelight conditions and measured using the MCID Elite v7.0 image analysis system (Interfocus, Haverhill, UK). Optical density values were calibrated to <sup>35</sup>SnCi/g tissue equivalents using the <sup>14</sup>C microscales. In the case of the neuronally expressed mRNAs, namely EAAT3 and the NMDAR subunits, measurements were taken over the stratum granulosum of the dentate gyrus, and over the stratum pyramidale of CA3 and CA1 subfields. In contrast, EAAT1 and EAAT2 mRNA and immunoreactivity were measured over a broadband distributed across the various strata of each subfield, reflecting the diffuse localization of these glial-expressed genes.</p>
        <p>All data were explored for normality using the Kolmogorov&#x2013;Smirnov test (in SPSS for Windows, v15.0). Group differences (knockout vs. wild-type) in the hippocampal expression of each gene were analyzed using ANOVA across all subfields examined; if a significant effect of genotype or genotype&#x2013;by&#x2013;subfield interactions were observed, separate analyses were performed in each subfield. Experiments on the mGluR2<sup>&#x2212;/&#x2212;</sup> and mGluR3<sup>&#x2212;/&#x2212;</sup> mice were conducted at different times (and compared with separate control groups), and were therefore analyzed separately.</p>
      </sec>
    </sec>
    <sec>
      <title>RESULTS</title>
      <p>The regional hippocampal distribution of each transcript was as reported previously: mGluR2 (<xref ref-type="bibr" rid="b37">Ohishi et al., 1993a</xref>), mGluR3 (<xref ref-type="bibr" rid="b38">Ohishi et al., 1993b</xref>), EAAT1 and EAAT2 (<xref ref-type="bibr" rid="b21">Ingram et al., 2001</xref>), EAAT3 (<xref ref-type="bibr" rid="b22">Kanai and Hediger, 1992</xref>), and NMDAR subunits (<xref ref-type="bibr" rid="b34">Monyer et al., 1992</xref>). Hybridization in the presence of excess unlabeled probe produced minimal background signal (not shown). The distribution of EAAT1 (<xref ref-type="bibr" rid="b43">Schmitt et al., 1997</xref>) and EAAT2 (<xref ref-type="bibr" rid="b40">Rothstein et al., 1994</xref>) immunoreactivity was also in agreement with previous findings and western blotting confirmed that the antibodies we used produced a single band of the expected &#x223C;65 kDa (EAAT1) and &#x223C;73 kDa (EAAT2) in mouse brain (data not shown).</p>
      <sec>
        <title>mGluR2 and mGluR3 mRNA</title>
        <p>Hybridization signals for mGluR2 (<xref ref-type="fig" rid="fig01">Fig. 1A</xref>) and mGluR3 (<xref ref-type="fig" rid="fig01">Fig. 1B</xref>) mRNA were present mainly over the dentate gyrus, and were only quantified over this subfield.</p>
        <fig id="fig01" position="float">
          <label>Fig. 1</label>
          <caption>
            <p><bold>A:</bold> mGluR2 mRNA distribution in wild types (left-hand panel); mGluR2 mRNA signal is increased in mGluR3<sup>&#x2212;/&#x2212;</sup> mice (right-hand panel). <bold>B:</bold> mGluR3 mRNA in wild types (left); mGluR3 mRNA is increased in mGluR2<sup>&#x2212;/&#x2212;</sup> mice (right). <bold>C:</bold> EAAT1 (GLAST) mRNA in wild types (left); EAAT1 (GLAST) mRNA is decreased in mGluR3<sup>&#x2212;/&#x2212;</sup> mice (right). <bold>D:</bold> EAAT2 (GLT-1) mRNA in wild types (left); EAAT2 (GLT-1) mRNA is unchanged in mGluR3<sup>&#x2212;/&#x2212;</sup> mice (right) and in mGluR2<sup>&#x2212;/&#x2212;</sup> mice (not shown). <bold>E:</bold> EAAT3 (EAAC1) mRNA in wild types (left); EAAT3 (EAAC1) mRNA is decreased in mGluR2<sup>&#x2212;/&#x2212;</sup> mice (right). <bold>F:</bold> NR2A mRNA in wild types (left); NR2A mRNA is increased in mGluR2<sup>&#x2212;/&#x2212;</sup> mice (right) and in mGluR3<sup>&#x2212;/&#x2212;</sup> mice (not shown). <bold>G:</bold> EAAT1 (GLAST) protein in wild types (left); EAAT1 (GLAST) protein is decreased in mGluR3<sup>&#x2212;/&#x2212;</sup> mice (right). <bold>H:</bold> EAAT2 (GLT-1) protein in wild types (left); EAAT2 (GLT-1) protein is decreased in mGluR3<sup>&#x2212;/&#x2212;</sup> mice (right) and in mGluR2<sup>&#x2212;/&#x2212;</sup> mice (not shown). Inset panels display hippocampal enlargements.</p>
          </caption>
          <graphic xlink:href="syn0062-0842-f1"/>
        </fig>
        <sec>
          <title>mGluR2 mRNA</title>
          <p>mGluR2 mRNA was increased in the mGluR3<sup>&#x2212;/&#x2212;</sup> mice compared with their wild&#x2013;type littermates (<italic>F</italic><sub>(1,10)</sub> = 14.81; <italic>P</italic> = 0.003; <xref ref-type="fig" rid="fig01">Figs. 1A</xref> and <xref ref-type="fig" rid="fig02">2A</xref>).</p>
          <fig id="fig02" position="float">
            <label>Fig. 2</label>
            <caption>
              <p>mGluR2 mRNA <bold>(A)</bold> is increased in the dentate gyrus of mGluR3&#x2212;/&#x2212; mice (n=6) compared to wild types (n=6), whereas mGluR3 mRNA <bold>(B)</bold> is increased in the dentate gyrus of mGluR2&#x2212;/&#x2212; mice (n=4) compared to wild types (n=4).</p>
            </caption>
            <graphic xlink:href="syn0062-0842-f2"/>
          </fig>
        </sec>
        <sec>
          <title>mGluR3 mRNA</title>
          <p>mGluR3 mRNA was increased in the mGluR2<sup>&#x2212;/&#x2212;</sup> mice compared with their wild&#x2013;type littermates (<italic>F</italic><sub>(1,6)</sub> = 23.14; <italic>P</italic> = 0.003) <xref ref-type="fig" rid="fig01">(Figs. 1B</xref> and <xref ref-type="fig" rid="fig02">2B</xref>).</p>
        </sec>
      </sec>
      <sec>
        <title>Glutamate transporter mRNAs</title>
        <sec>
          <title>EAAT1 (GLAST) mRNA</title>
          <p>For EAAT1 mRNA, in mGluR2<sup>&#x2212;/&#x2212;</sup> mice there was no effect of genotype and no genotype&#x2013;by&#x2013;subfield interaction (both <italic>F</italic> &lt; 1, <italic>P</italic> &gt; 0.20). By contrast, mGluR3<sup>&#x2212;/&#x2212;</sup> mice showed a main effect of genotype (<italic>F</italic><sub>(1,20)</sub> = 15.22; <italic>P</italic> &lt; 0.001) as well as a trend genotype&#x2013;by&#x2013;subfield interaction (<italic>F</italic><sub>(1,20)</sub> = 3.68; <italic>P</italic> = 0.070). Subsequent analysis revealed that EAAT1 mRNA was reduced in both the dentate gyrus (<italic>F</italic><sub>(1,10)</sub> = 9.77; <italic>P</italic> = 0.011) and CA1 (<italic>F</italic><sub>(1,10)</sub> = 7.38; <italic>P</italic> = 0.022) of mGluR3<sup>&#x2212;/&#x2212;</sup> mice compared with their wild-type littermates (<xref ref-type="table" rid="tbl2">Table II</xref>; <xref ref-type="fig" rid="fig01">Fig. 1C</xref>).</p>
          <table-wrap id="tbl2" position="float">
            <label>TABLE II</label>
            <caption>
              <p>Hippocampal expression of <italic>EAAT1 (GLAST) mRNA</italic> and protein, <italic>EAAT2 (GLT&#x2013;1)</italic> mRNA and protein, <italic>EAAT3 (EAAC1)</italic> mRNA,and NR1, NR2A, and NR2B mRNA in mGluR2&#x2212;/&#x2212; and mGluR3&#x2212;/&#x2212; mice</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th align="center" rowspan="1" colspan="1"/>
                  <th align="center" rowspan="1" colspan="1"/>
                  <th align="center" rowspan="1" colspan="1"/>
                  <th align="center" colspan="2" rowspan="1">mGluR2</th>
                  <th align="center" colspan="2" rowspan="1">mGluR3</th>
                </tr>
                <tr>
                  <th align="center" rowspan="1" colspan="1"/>
                  <th align="center" rowspan="1" colspan="1"/>
                  <th align="center" rowspan="1" colspan="1"/>
                  <th align="center" colspan="2" rowspan="1">
                    <hr/>
                  </th>
                  <th align="center" colspan="2" rowspan="1">
                    <hr/>
                  </th>
                </tr>
                <tr>
                  <th align="center" rowspan="1" colspan="1">Gene</th>
                  <th align="center" rowspan="1" colspan="1"/>
                  <th align="center" rowspan="1" colspan="1"/>
                  <th align="center" rowspan="1" colspan="1">wt(n=5)</th>
                  <th align="center" rowspan="1" colspan="1">ko(n=4&#x2013;6)</th>
                  <th align="center" rowspan="1" colspan="1">wt(n=6)</th>
                  <th align="center" rowspan="1" colspan="1">ko(n=6)</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left" rowspan="1" colspan="1">EAATI</td>
                  <td align="left" rowspan="1" colspan="1">mRNA<xref ref-type="table-fn" rid="tf2-1">a</xref></td>
                  <td align="left" rowspan="1" colspan="1">DG</td>
                  <td align="left" rowspan="1" colspan="1">279&#xB1;13</td>
                  <td align="left" rowspan="1" colspan="1">264&#xB1;17</td>
                  <td align="left" rowspan="1" colspan="1">259&#xB1;14</td>
                  <td align="left" rowspan="1" colspan="1">210&#xB1;<xref ref-type="table-fn" rid="tf2-8">*</xref></td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">CAI</td>
                  <td align="left" rowspan="1" colspan="1">159&#xB1;5</td>
                  <td align="left" rowspan="1" colspan="1">159&#xB1;11</td>
                  <td align="left" rowspan="1" colspan="1">142&#xB1;5</td>
                  <td align="left" rowspan="1" colspan="1">125&#xB1;4<xref ref-type="table-fn" rid="tf2-8">*</xref></td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">protein<xref ref-type="table-fn" rid="tf2-2">b</xref></td>
                  <td align="left" rowspan="1" colspan="1">DG</td>
                  <td align="left" rowspan="1" colspan="1">1210&#xB1;123</td>
                  <td align="left" rowspan="1" colspan="1">1206&#xB1;75</td>
                  <td align="left" rowspan="1" colspan="1">453&#xB1;22</td>
                  <td align="left" rowspan="1" colspan="1">375&#xB1;18<xref ref-type="table-fn" rid="tf2-8">*</xref></td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">EAAT2</td>
                  <td align="left" rowspan="1" colspan="1">mRNA</td>
                  <td align="left" rowspan="1" colspan="1">CAI</td>
                  <td align="left" rowspan="1" colspan="1">1343&#xB1;92</td>
                  <td align="left" rowspan="1" colspan="1">1283&#xB1;85</td>
                  <td align="left" rowspan="1" colspan="1">460&#xB1;</td>
                  <td align="left" rowspan="1" colspan="1">372&#xB1;18<xref ref-type="table-fn" rid="tf2-8">*</xref></td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">DG</td>
                  <td align="left" rowspan="1" colspan="1">1357&#xB1;99</td>
                  <td align="left" rowspan="1" colspan="1">1339&#xB1;51</td>
                  <td align="left" rowspan="1" colspan="1">1425&#xB1;88</td>
                  <td align="left" rowspan="1" colspan="1">1479&#xB1;100</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">CA3</td>
                  <td align="left" rowspan="1" colspan="1">2455&#xB1;29</td>
                  <td align="left" rowspan="1" colspan="1">2588&#xB1;</td>
                  <td align="left" rowspan="1" colspan="1">2141&#xB1;151</td>
                  <td align="left" rowspan="1" colspan="1">2147&#xB1;187</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">CAI</td>
                  <td align="left" rowspan="1" colspan="1">956&#xB1;44</td>
                  <td align="left" rowspan="1" colspan="1">944&#xB1;32</td>
                  <td align="left" rowspan="1" colspan="1">745&#xB1;40</td>
                  <td align="left" rowspan="1" colspan="1">722&#xB1;49</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">protein<xref ref-type="table-fn" rid="tf2-3">c</xref></td>
                  <td align="left" rowspan="1" colspan="1">DG</td>
                  <td align="left" rowspan="1" colspan="1">1160&#xB1;67</td>
                  <td align="left" rowspan="1" colspan="1">1259&#xB1;42</td>
                  <td align="left" rowspan="1" colspan="1">1733&#xB1;58</td>
                  <td align="left" rowspan="1" colspan="1">1542&#xB1;53<xref ref-type="table-fn" rid="tf2-8">*</xref></td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">CA3</td>
                  <td align="left" rowspan="1" colspan="1">1037&#xB1;62</td>
                  <td align="left" rowspan="1" colspan="1">1070&#xB1;24</td>
                  <td align="left" rowspan="1" colspan="1">1591&#xB1;42</td>
                  <td align="left" rowspan="1" colspan="1">1454&#xB1;38<xref ref-type="table-fn" rid="tf2-8">*</xref></td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">CAI</td>
                  <td align="left" rowspan="1" colspan="1">1081&#xB1;33</td>
                  <td align="left" rowspan="1" colspan="1">1087&#xB1;54</td>
                  <td align="left" rowspan="1" colspan="1">1699&#xB1;51</td>
                  <td align="left" rowspan="1" colspan="1">1459&#xB1;43<xref ref-type="table-fn" rid="tf2-9">**</xref></td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">EAAT3</td>
                  <td align="left" rowspan="1" colspan="1">mRNA<xref ref-type="table-fn" rid="tf2-4">d</xref></td>
                  <td align="left" rowspan="1" colspan="1">DG</td>
                  <td align="left" rowspan="1" colspan="1">3148&#xB1;351</td>
                  <td align="left" rowspan="1" colspan="1">2046&#xB1;362</td>
                  <td align="left" rowspan="1" colspan="1">2579&#xB1;276</td>
                  <td align="left" rowspan="1" colspan="1">2684&#xB1;229</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">CA3</td>
                  <td align="left" rowspan="1" colspan="1">1612&#xB1;382</td>
                  <td align="left" rowspan="1" colspan="1">941&#xB1;122</td>
                  <td align="left" rowspan="1" colspan="1">1652&#xB1;286</td>
                  <td align="left" rowspan="1" colspan="1">1746&#xB1;252</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">CAI</td>
                  <td align="left" rowspan="1" colspan="1">1741&#xB1;144</td>
                  <td align="left" rowspan="1" colspan="1">1058&#xB1;104<xref ref-type="table-fn" rid="tf2-9">**</xref></td>
                  <td align="left" rowspan="1" colspan="1">1917&#xB1;277</td>
                  <td align="left" rowspan="1" colspan="1">1990&#xB1;253</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">NRI</td>
                  <td align="left" rowspan="1" colspan="1">mRNA<xref ref-type="table-fn" rid="tf2-5">e</xref></td>
                  <td align="left" rowspan="1" colspan="1">DG</td>
                  <td align="left" rowspan="1" colspan="1">1449&#xB1;45</td>
                  <td align="left" rowspan="1" colspan="1">1539&#xB1;49</td>
                  <td align="left" rowspan="1" colspan="1">1485&#xB1;68</td>
                  <td align="left" rowspan="1" colspan="1">1534&#xB1;48</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">CA3</td>
                  <td align="left" rowspan="1" colspan="1">1454&#xB1;78</td>
                  <td align="left" rowspan="1" colspan="1">1289&#xB1;47</td>
                  <td align="left" rowspan="1" colspan="1">1337&#xB1;77</td>
                  <td align="left" rowspan="1" colspan="1">1456&#xB1;33</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">CAI</td>
                  <td align="left" rowspan="1" colspan="1">1377&#xB1;58</td>
                  <td align="left" rowspan="1" colspan="1">1554&#xB1;92</td>
                  <td align="left" rowspan="1" colspan="1">1535&#xB1;65</td>
                  <td align="left" rowspan="1" colspan="1">1593&#xB1;37</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">NR2A</td>
                  <td align="left" rowspan="1" colspan="1">mRNA<xref ref-type="table-fn" rid="tf2-6">f</xref>, <xref ref-type="table-fn" rid="tf2-6">g</xref></td>
                  <td align="left" rowspan="1" colspan="1">DG</td>
                  <td align="left" rowspan="1" colspan="1">811&#xB1;17</td>
                  <td align="left" rowspan="1" colspan="1">1011&#xB1;49<xref ref-type="table-fn" rid="tf2-8">*</xref></td>
                  <td align="left" rowspan="1" colspan="1">1326&#xB1;34</td>
                  <td align="left" rowspan="1" colspan="1">1507&#xB1;53<xref ref-type="table-fn" rid="tf2-8">*</xref></td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">CA3</td>
                  <td align="left" rowspan="1" colspan="1">723&#xB1;55</td>
                  <td align="left" rowspan="1" colspan="1">693&#xB1;49</td>
                  <td align="left" rowspan="1" colspan="1">1061&#xB1;34</td>
                  <td align="left" rowspan="1" colspan="1">1172&#xB1;33<xref ref-type="table-fn" rid="tf2-8">*</xref></td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">CAI</td>
                  <td align="left" rowspan="1" colspan="1">979&#xB1;65</td>
                  <td align="left" rowspan="1" colspan="1">1104&#xB1;71</td>
                  <td align="left" rowspan="1" colspan="1">1467&#xB1;69</td>
                  <td align="left" rowspan="1" colspan="1">1611&#xB1;80</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">NR2B</td>
                  <td align="left" rowspan="1" colspan="1">mRNA</td>
                  <td align="left" rowspan="1" colspan="1">DG</td>
                  <td align="left" rowspan="1" colspan="1">913&#xB1;26</td>
                  <td align="left" rowspan="1" colspan="1">948&#xB1;31</td>
                  <td align="left" rowspan="1" colspan="1">1087&#xB1;45</td>
                  <td align="left" rowspan="1" colspan="1">1037&#xB1;20</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">CA3</td>
                  <td align="left" rowspan="1" colspan="1">840&#xB1;40</td>
                  <td align="left" rowspan="1" colspan="1">784&#xB1;54</td>
                  <td align="left" rowspan="1" colspan="1">912&#xB1;30</td>
                  <td align="left" rowspan="1" colspan="1">886&#xB1;37</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">CAI</td>
                  <td align="left" rowspan="1" colspan="1">1111&#xB1;42</td>
                  <td align="left" rowspan="1" colspan="1">1184&#xB1;20</td>
                  <td align="left" rowspan="1" colspan="1">1344&#xB1;80</td>
                  <td align="left" rowspan="1" colspan="1">1378&#xB1;54</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>Values are mean <sup>35</sup>SnCi/g tissue equivalents &#xB1;SEM</p>
              </fn>
              <fn>
                <p>wt, wilg type;ko, knockout</p>
              </fn>
              <fn id="tf2-1">
                <label>a</label>
                <p>Main effect of genotype in mGluR3<sup>&#x2212;/&#x2212;</sup> mice, <italic>P</italic>&lt;0.001(univariate ANOVA)</p>
              </fn>
              <fn id="tf2-2">
                <label>b</label>
                <p>Main effect of genotype in mGluR3<sup>&#x2212;/&#x2212;</sup> mice, <italic>P</italic>=0.001(univariate ANOVA)</p>
              </fn>
              <fn id="tf2-3">
                <label>c</label>
                <p>Main effect of genotype in mGluR3<sup>&#x2212;/&#x2212;</sup> mice, <italic>P</italic>&lt;0.001(univariate ANOVA)</p>
              </fn>
              <fn id="tf2-4">
                <label>d</label>
                <p>Main effect of genotype in mGluR3<sup>&#x2212;/&#x2212;</sup> mice, <italic>P</italic>&lt;0.001(univariate ANOVA)</p>
              </fn>
              <fn id="tf2-5">
                <label>e</label>
                <p>Genotype by subfield interaction in mGluR2<sup>&#x2212;/&#x2212;</sup>mice, <italic>P</italic>=0.033(univariate ANOVA)</p>
              </fn>
              <fn id="tf2-6">
                <label>f</label>
                <p>Main effect of genotype in mGluR2<sup>&#x2212;/&#x2212;</sup> mice, <italic>P</italic>=0.045 (univariate ANOVA)</p>
              </fn>
              <fn id="tf2-7">
                <label>g</label>
                <p>Main effect of genotype in mGluR3<sup>&#x2212;/&#x2212;</sup> mice, <italic>P</italic>=0.002(univariate ANOVA)</p>
              </fn>
              <fn id="tf2-8">
                <label>*</label>
                <p><italic>P</italic>&lt;0.05</p>
              </fn>
              <fn id="tf2-9">
                <label>**</label>
                <p><italic>P</italic>&lt;0.01, post&#x2013;hoc comparisons (one&#x2013;way ANOVA)</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
        <sec>
          <title>EAAT2 (GLT-1) mRNA</title>
          <p>For EAAT2 mRNA there was no effect of genotype or no genotype&#x2013;by&#x2013;subfield interaction, in either mGluR2<sup>&#x2212;/&#x2212;</sup> or mGluR3<sup>&#x2212;/&#x2212;</sup> mice (all <italic>F</italic> &lt; 1, P &gt; 0.20) (<xref ref-type="table" rid="tbl2">Table II</xref>; <xref ref-type="fig" rid="fig01">Fig. 1D</xref>).</p>
        </sec>
        <sec>
          <title>EAAT3 (EAAC1) mRNA</title>
          <p>In mGluR2<sup>&#x2212;/&#x2212;</sup> mice, EAAT3 mRNA showed a main effect of genotype (<italic>F</italic><sub>(1,21)</sub> = 14.80; <italic>P</italic> &lt; 0.001) but no interaction with subfield (<italic>F</italic> &lt; 1; <italic>P</italic> &gt; 0.20). One&#x2013;way ANOVA confirmed that EAAT3 mRNA was reduced throughout the mGluR2<sup>&#x2212;/&#x2212;</sup> hippocampus, significantly in CA1 (<italic>F</italic><sub>(1,7)</sub> = 13.27; <italic>P</italic> = 0.008) and at trend significance in dentate gyrus (<italic>F</italic><sub>(1,7)</sub> = 4.69; <italic>P</italic> = 0.067) and CA3 (<italic>F</italic><sub>(1,7)</sub> = 3.98; <italic>P</italic> = 0.086) (<xref ref-type="fig" rid="fig03">Fig. 3E</xref>). EAAT3 mRNA was unaltered in mGluR3<sup>&#x2212;/&#x2212;</sup> mice, with no effect of genotype and no genotype&#x2013;by&#x2013;subfield interaction (both <italic>F</italic> &lt; 1; <italic>P</italic> &gt; 0.20) (<xref ref-type="table" rid="tbl2">Table II</xref>;).</p>
          <fig id="fig03" position="float">
            <label>Fig. 3</label>
            <caption>
              <p>NR2A mRNA is increased in the hippocampus of both (<bold>A</bold>) mGluR2<sup>&#x2212;/&#x2212;</sup> (n = 6) compared to wild type (n = 6) and (<bold>B</bold>) mGluR3<sup>&#x2212;/&#x2212;</sup> (n = 5) compared to wild type (n = 5) mice.</p>
            </caption>
            <graphic xlink:href="syn0062-0842-f3"/>
          </fig>
        </sec>
      </sec>
      <sec>
        <title>Glutamate transporter proteins</title>
        <sec>
          <title>EAAT1 (GLAST)</title>
          <p>Results for EAAT1 immunoreactivity were similar to those for EAAT1 mRNA. Thus, in mGluR2<sup>&#x2212;/&#x2212;</sup> mice, there was no effect of genotype and no genotype&#x2013;by&#x2013;subfield interaction (both <italic>F</italic> &lt; 1; <italic>P</italic> &gt; 0.20). In mGluR3<sup>&#x2212;/&#x2212;</sup> animals, there was an effect of genotype (<italic>F</italic><sub>(1,20)</sub> = 15.62; <italic>P</italic> = 0.001), but no genotype-by-subfield interaction (<italic>F</italic> &lt; 1; <italic>P</italic> &gt; 0.20). EAAT1 immunoreactivity was reduced in a fairly uniform manner throughout the mGluR3<sup>&#x2212;/&#x2212;</sup> hippocampus (dentate gyrus: <italic>F</italic><sub>(1,10)</sub> = 7.60; <italic>P</italic> = 0.02; CA1: <italic>F</italic><sub>(1,10)</sub> = 8.03; <italic>P</italic> = 0.018) (<xref ref-type="table" rid="tbl2">Table II</xref>; <xref ref-type="fig" rid="fig01">Fig. 1G</xref>).</p>
        </sec>
        <sec>
          <title>EAAT2 (GLT&#x2013;1)</title>
          <p>EAAT2 immunoreactivity was not changed in mGluR2<sup>&#x2212;/&#x2212;</sup> animals, with no effect of genotype, and no genotype-by-subfield interaction (both <italic>F</italic> &lt; 1; <italic>P</italic> &gt; 0.20). In mGluR3<sup>&#x2212;/&#x2212;</sup> animals, by contrast, there was a main effect of genotype (<italic>F</italic><sub>(1,30)</sub> = 24.78; <italic>P</italic> &lt; 0.001) although no genotype&#x2013;by&#x2013;subfield interaction (<italic>F</italic> &lt; 1; <italic>P</italic> &gt; 0.20). Consistent with these findings, EAAT2 immunoreactivity was reduced in all subfields of the mGluR3<sup>&#x2212;/&#x2212;</sup> hippocampus (dentate gyrus: <italic>F</italic><sub>(1,10)</sub> = 5.98; <italic>P</italic> = 0.035; CA3: <italic>F</italic><sub>(1,10)</sub> = 5.86; <italic>P</italic> = 0.036; CA1: <italic>F</italic><sub>(1,10)</sub> = 15.60; <italic>P</italic> = 0.003) (<xref ref-type="table" rid="tbl1">Table II</xref>; <xref ref-type="fig" rid="fig01">Fig. 1H</xref>).</p>
        </sec>
      </sec>
      <sec>
        <title>NMDA receptor subunit mRNAs</title>
        <sec>
          <title>NR1 mRNA</title>
          <p>In mGluR2<sup>&#x2212;/&#x2212;</sup> mice, there was no effect of genotype on NR1 mRNA (<italic>F</italic> &lt; 1; <italic>P</italic> &gt; 0.20) but there was a genotype&#x2013;by&#x2013;subfield interaction (<italic>F</italic><sub>(2,27)</sub> = 3.98; <italic>P</italic> = 0.033). The latter reflected a small decrease in the knockouts in CA3 and an increase in CA1; however, neither change was significant in the post hoc test (CA3: <italic>F</italic><sub>(1,9)</sub> = 2.97; <italic>P</italic> = 0.119; CA1: <italic>F</italic><sub>(1,9)</sub> = 2.86; <italic>P</italic> = 0.125). NR1 mRNA was unaltered in mGluR3<sup>&#x2212;/&#x2212;</sup> mice, with no effect of genotype or no genotype&#x2013;bysubfield interaction (both <italic>F</italic> &lt; 1, <italic>P</italic> &gt; 0.2) (<xref ref-type="table" rid="tbl2">Table II</xref>).</p>
        </sec>
        <sec>
          <title>NR2A mRNA</title>
          <p>In mGluR2<sup>&#x2212;/&#x2212;</sup> mice, there was an effect of genotype on NR2A mRNA (<italic>F</italic><sub>(1,26)</sub> = 4.44; <italic>P</italic> = 0.045), but no interaction with subfield (<italic>F</italic><sub>(2,26)</sub> = 2.09; <italic>P</italic> = 0.145). One&#x2013;way ANOVA confirmed that NR2A mRNA was increased in the dentate gyrus (<italic>F</italic><sub>(1,8)</sub> = 10.17; <italic>P</italic> = 0.013), but not significantly in CA3 or CA1 (both <italic>F</italic> &lt; 1; <italic>P</italic> &gt; 0.20) (<xref ref-type="table" rid="tbl2">Table II</xref>; <xref ref-type="fig" rid="fig01">Figs. 1F</xref> and <xref ref-type="fig" rid="fig03">3A</xref>). In mGluR3<sup>&#x2212;/&#x2212;</sup> mice, there was again a main effect of genotype for NR2A mRNA (<italic>F</italic><sub>(1,27)</sub> = 11.14; <italic>P</italic> = 0.002), but no genotype&#x2013;by&#x2013;subfield interaction (<italic>F</italic> &lt; 1; <italic>P</italic> &gt; 0.20). Post hoc tests showed NR2A mRNA increased in the dentate gyrus (<italic>F</italic><sub>(1,9)</sub> = 5.73; <italic>P</italic> = 0.04) and CA3 (<italic>F</italic><sub>(1,9)</sub> = 5.35; <italic>P</italic> = 0.046) but not CA1 (<italic>F</italic><sub>(1,9)</sub> = 1.89; <italic>P</italic> = 0.203) of mGluR3<sup>&#x2212;/&#x2212;</sup> mice (<xref ref-type="table" rid="tbl2">Table II</xref>; <xref ref-type="fig" rid="fig03">Fig. 3B</xref>).</p>
        </sec>
        <sec>
          <title>NR2B mRNA</title>
          <p>NR2B mRNA was unchanged in both knockout mice (all <italic>F</italic> &lt; 1.7; <italic>P</italic> &gt; 0.20) (<xref ref-type="table" rid="tbl1">Table II</xref>).</p>
        </sec>
      </sec>
    </sec>
    <sec>
      <title>DISCUSSION</title>
      <p>Determining the individual properties of the two group II mGluRs, mGluR2 and mGluR3, has been problematic because of a dearth of suitable selective ligands and antibodies. The generation of mGluR2<sup>&#x2212;/&#x2212;</sup> and mGluR3<sup>&#x2212;/&#x2212;</sup> mice has therefore been an important step forward. Use of these mice has, for example, showed a prominent role for mGluR2 in mossy fiber long term depression (<xref ref-type="bibr" rid="b54">Yokoi et al., 1996</xref>) and for mGluR3 in neuroprotection (<xref ref-type="bibr" rid="b8">Corti et al., 2007b</xref>), and for both receptors in the anxiolytic response to a mGluR2/3 agonist (<xref ref-type="bibr" rid="b27">Linden et al., 2005</xref>). However, these studies have not investigated whether expression of the surviving group II mGluR, or indeed expression of other genes involved in glutamate neurotransmission, is altered in each knockout mouse. Such information is clearly relevant when interpreting their phenotype and extrapolating to the function(s) of the receptors. Here, in parallel experiments, we have studied the hippocampal expression of seven glutamatergic transcripts, and two of the encoded proteins, in mGluR2<sup>&#x2212;/&#x2212;</sup> and mGluR3<sup>&#x2212;/&#x2212;</sup> mice. Our results show that knockout of either gene leads to upregulation of the remaining group II mGluR and upregulation of the NR2A subunit of the NMDA receptor, as well as to downregulation of glutamate transporters. However, the identity of the affected transporter differs between the mice: loss of mGluR2 leads to a decrease of the neuronal EAAT3, whereas deletion of mGluR3 results in reduction of the glial transporters EAAT1 and EAAT2.</p>
      <p>A notable finding was the increase of mGluR3 expression in mGluR2<sup>&#x2212;/&#x2212;</sup> mice, and vice versa, which suggests a mutual&#x2014;albeit partial&#x2014;compensatory response to the loss of a group II mGluR, which may contribute to the relatively mild behavioral phenotype seen in both mice, particularly mGluR3 knockouts. Equally, the increase was only modest in percentage terms, which may explain why deletion of either gene is not without demonstrable electrophysiological and behavioral consequences (for review, see <xref ref-type="bibr" rid="b20">Harrison et al., in press</xref>). Complementary studies of the encoded proteins will be needed to confirm the localization and magnitude of the reciprocal upregulation.</p>
      <p>Group II mGluRs have complex interactions with, and effects upon, NMDA receptors (<xref ref-type="bibr" rid="b33">Moghaddam and Adams, 1998</xref>), and it is thus of interest that, in both mGluR2<sup>&#x2212;/&#x2212;</sup> and mGluR3<sup>&#x2212;/&#x2212;</sup> mice, the NR2A subunit was selectively upregulated, with no alteration in either NR1 or NR2B subunit mRNAs. This finding follows a previous report that the mGluR2/3 agonist APDC enhances NMDA-evoked responses in dissociated rat prefrontal cortex neurons, predominantly via NR2A-containing receptors (<xref ref-type="bibr" rid="b52">Tyszkiewicz et al., 2004</xref>). Our data imply that an increased proportion of hippocampal NMDARs in mGluR2<sup>&#x2212;/&#x2212;</sup> and mGluR3<sup>&#x2212;/&#x2212;</sup> mice contain an NR2A rather than NR2B subunit. This difference will likely influence their properties in several ways, including calcium flux and channel opening kinetics, postsynaptic protein coupling, and perhaps long-term potentiation (<xref ref-type="bibr" rid="b9">Cull-Candy et al., 2001</xref>; <xref ref-type="bibr" rid="b28">Liu et al., 2004</xref>; <xref ref-type="bibr" rid="b35">Monyer et al., 1994</xref>; <xref ref-type="bibr" rid="b44">Sheng et al., 2000</xref>). The net functional effect of a more &#x201C;NR2A&#x2013;dominant&#x201D; NMDA receptor population, in the presence of a lack of one or other group II mGluR, remains to be determined and will benefit from electrophysiological approaches.</p>
      <p>A major role of group II mGluRs, especially mGluR2, is as inhibitory autoreceptors (<xref ref-type="bibr" rid="b1">Anwyl, 1999</xref>; <xref ref-type="bibr" rid="b3">Cartmell and Schoepp, 2000</xref>; <xref ref-type="bibr" rid="b23">Kew et al., 2002</xref>). Our results show that one consequence of deletion of either receptor is a downregulation of glutamate transporter expression. This presumably is a response to an altered level of synaptic or extra-synaptic glutamate, in turn supporting the role in vivo of both receptors in regulating synaptic glutamate release. However, three points regarding the altered EAAT expression are noteworthy. The first concerns the direction of effect. Simplistically, the loss of a group II mGluR might be predicted to increase glutamate release and thence extracellular glutamate levels, and hence that the transporters might be upregulated as part of a homeostatic response, as has been suggested for EAAT1 in cortical astrocytes (<xref ref-type="bibr" rid="b15">Gegelashvili et al., 1996</xref>). On the other hand, our finding is consistent with <xref ref-type="bibr" rid="b2">Aronica et al. (2003)</xref>, who showed that mGluR3 activation increases glial glutamate transporter expression in vitro. These diverse findings emphasize that the regulation of EAAT expression and activity are complex and incompletely understood (<xref ref-type="bibr" rid="b14">Gegelashvili and Schousboe, 1997</xref>; <xref ref-type="bibr" rid="b46">Shigeri et al., 2004</xref>), and so until the effect of group II mGluR deletion on glutamate release and/or extracellular glutamate levels is known, it will remain difficult to interpret the cause and significance of the decreased glutamate transporter expression observed here.</p>
      <p>The second point concerns the identity of the specific transporters affected in the two mouse lines. The glial glutamate transporters EAAT1 and EAAT2 were downregulated in mGluR3<sup>&#x2212;/&#x2212;</sup> mice but unchanged in mGluR2<sup>&#x2212;/&#x2212;</sup> mice. In contrast, the neuronal glutamate transporter EAAT3 was reduced in the mGluR2 knockouts but unchanged in their mGluR3<sup>&#x2212;/&#x2212;</sup> counterparts. It is tempting to relate this profile to the fact that mGluR2 is exclusively neuronally expressed (<xref ref-type="bibr" rid="b45">Shigemoto et al., 1997</xref>), whereas mGluR3 is prominently and additionally expressed in astrocytes and other glial subtypes (<xref ref-type="bibr" rid="b53">Wroblewska et al., 1998</xref>). It is also of note that, in human brain, polymorphic variation in mGluR3 impacts on EAAT2 expression (<xref ref-type="bibr" rid="b12">Egan et al., 2004</xref>). Third, while EAAT1 mRNA and protein levels were both reduced, EAAT2 protein alone was downregulated, with EAAT2 mRNA remaining unchanged. This supports other studies showing that EAAT2 expression is regulated primarily at the translational level (<xref ref-type="bibr" rid="b14">Gegelashvili and Schousboe, 1997</xref>; <xref ref-type="bibr" rid="b51">Tian et al., 2007</xref>).</p>
      <p>In summary, this study has shown that deletion of either mGluR2 or mGluR3 genes produces changes in the hippocampal expression of several other genes involved in glutamatergic neurotransmission. Such changes should be considered when interpreting the phenotype of the mice in behavioral, electrophysiological, and pharmacological studies. The fact that the changes are broadly similar in both mice is consistent with the grouping of mGluR2 and mGluR3 together as group II mGluRs, and for a significant overlap in their functional roles. Equally, the distinct profile of glutamate transporter alterations in mGluR2<sup>&#x2212;/&#x2212;</sup> vs. mGluR3<sup>&#x2212;/&#x2212;</sup> mice supports the emerging evidence for specific differences in the expression and properties of the two receptors (<xref ref-type="bibr" rid="b8">Corti et al., 2007b</xref>; <xref ref-type="bibr" rid="b20">Harrison et al., in press</xref>). Further studies need to include other brain regions, developmental stages, and additional transcripts and proteins. In particular, the expression of other glutamate receptors, most notably AMPAR subunits and additional presynaptic mGluRs, could usefully be examined. The continuing dissection of the molecular phenotype of mGluR2<sup>&#x2212;/&#x2212;</sup> and mGluR3<sup>&#x2212;/&#x2212;</sup> mice will contribute to the understanding of the relative contribution of each receptor in the aetiopathogenesis and pharmacotherapy of schizophrenia and other psychiatric disorders in which they are increasingly implicated.</p>
    </sec>
  </body>
  <back>
    <ack>
      <p content-type="acknowledgment">L.L. holds a Wellcome Trust M.Sc./D.Phil. studentship. Additional support was provided by the Medical Research Council and the Stanley Medical Research Institute. The authors thank Professor Shigetada Nakanishi for the generous provision of the mGluR2<sup>&#x2212;/&#x2212;</sup> mice.</p>
    </ack>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="b1">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Anwyl</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Metabotropic glutamate receptors: Electrophysiological properties and role in plasticity</article-title>
          <source>Brain Res Brain Res Rev</source>
          <year>1999</year>
          <volume>29</volume>
          <fpage>83</fpage>
          <lpage>120</lpage>
          <pub-id pub-id-type="pmid">9974152</pub-id>
        </citation>
      </ref>
      <ref id="b2">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aronica</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Gorter</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Ijlst-Keizers</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Rozemuller</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Yankaya</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Leenstra</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Troost</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Expression and functional role of mGluR3 and mGluR5 in human astrocytes and glioma cells: Opposite regulation of glutamate transporter proteins</article-title>
          <source>Eur J Neurosci</source>
          <year>2003</year>
          <volume>17</volume>
          <fpage>2106</fpage>
          <lpage>2118</lpage>
          <pub-id pub-id-type="pmid">12786977</pub-id>
        </citation>
      </ref>
      <ref id="b3">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cartmell</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Schoepp</surname>
              <given-names>DD</given-names>
            </name>
          </person-group>
          <article-title>Regulation of neurotransmitter release by metabotropic glutamate receptors</article-title>
          <source>J Neurochem</source>
          <year>2000</year>
          <volume>75</volume>
          <fpage>889</fpage>
          <lpage>907</lpage>
          <pub-id pub-id-type="pmid">10936169</pub-id>
        </citation>
      </ref>
      <ref id="b4">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cartmell</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Monn</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Schoepp</surname>
              <given-names>DD</given-names>
            </name>
          </person-group>
          <article-title>The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats</article-title>
          <source>J Pharmacol Exp Ther</source>
          <year>1999</year>
          <volume>291</volume>
          <fpage>161</fpage>
          <lpage>170</lpage>
          <pub-id pub-id-type="pmid">10490900</pub-id>
        </citation>
      </ref>
      <ref id="b5">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Catania</surname>
              <given-names>MV</given-names>
            </name>
            <name>
              <surname>Landwehrmeyer</surname>
              <given-names>GB</given-names>
            </name>
            <name>
              <surname>Testa</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Standaert</surname>
              <given-names>DG</given-names>
            </name>
            <name>
              <surname>Penney</surname>
              <given-names>JB</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Young</surname>
              <given-names>AB</given-names>
            </name>
          </person-group>
          <article-title>Metabotropic glutamate receptors are differentially regulated during development</article-title>
          <source>Neuroscience</source>
          <year>1994</year>
          <volume>61</volume>
          <fpage>481</fpage>
          <lpage>495</lpage>
          <pub-id pub-id-type="pmid">7969925</pub-id>
        </citation>
      </ref>
      <ref id="b6">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Corti</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Andreoli</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Marcon</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Zambon</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Heidbreder</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Mugnaini</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Generation and characterization of mGluR3 deficient mice in models of alcohol dependence</article-title>
          <source>Society for Neuroscience</source>
          <year>2004</year>
          <comment>San Diego, USA. Abstract Viewer Program No. 234.15</comment>
        </citation>
      </ref>
      <ref id="b7">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Corti</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Crepaldi</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Mion</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Roth</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Xuereb</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Ferraguti</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Altered dimerization of metabotropic glutamate receptor 3 in schizophrenia</article-title>
          <source>Biol Psychiatry</source>
          <year>2007a</year>
          <volume>62</volume>
          <fpage>747</fpage>
          <lpage>755</lpage>
          <pub-id pub-id-type="pmid">17531207</pub-id>
        </citation>
      </ref>
      <ref id="b8">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Corti</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Battaglia</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Molinaro</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Riozzi</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Pittaluga</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Corsi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mugnaini</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nicoletti</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Bruno</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>The use of knock-out mice unravels distinct roles for mGlu2 and mGlu3 metabotropic glutamate receptors in mechanisms of neurodegeneration/neuroprotection</article-title>
          <source>J Neurosci</source>
          <year>2007b</year>
          <volume>27</volume>
          <fpage>8297</fpage>
          <lpage>8308</lpage>
          <pub-id pub-id-type="pmid">17670976</pub-id>
        </citation>
      </ref>
      <ref id="b9">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cull-Candy</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Brickley</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Farrant</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>NMDA receptor subunits: Diversity, development and disease</article-title>
          <source>Curr Opin Neurobiol</source>
          <year>2001</year>
          <volume>11</volume>
          <fpage>327</fpage>
          <lpage>335</lpage>
          <pub-id pub-id-type="pmid">11399431</pub-id>
        </citation>
      </ref>
      <ref id="b10">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dunayevich</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Erickson</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Levine</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Landbloom</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Schoepp</surname>
              <given-names>DD</given-names>
            </name>
            <name>
              <surname>Tollefson</surname>
              <given-names>GD</given-names>
            </name>
          </person-group>
          <article-title>Efficacy and tolerability of an mGlu2/3 agonist in the treatment of generalized anxiety disorder</article-title>
          <source>Neuropsychopharmacology</source>
          <year>2007</year>
          <volume>33</volume>
          <fpage>1603</fpage>
          <lpage>1610</lpage>
          <pub-id pub-id-type="pmid">17712352</pub-id>
        </citation>
      </ref>
      <ref id="b11">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eastwood</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Lyon</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>George</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Andrieux</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Job</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Harrison</surname>
              <given-names>PJ</given-names>
            </name>
          </person-group>
          <article-title>Altered expression of synaptic protein mRNAs in STOP (MAP6) mutant mice</article-title>
          <source>J Psychopharmacol</source>
          <year>2007</year>
          <volume>21</volume>
          <fpage>635</fpage>
          <lpage>644</lpage>
          <pub-id pub-id-type="pmid">17050659</pub-id>
        </citation>
      </ref>
      <ref id="b12">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Egan</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Straub</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Goldberg</surname>
              <given-names>TE</given-names>
            </name>
            <name>
              <surname>Yakub</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Callicott</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Hariri</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Mattay</surname>
              <given-names>VS</given-names>
            </name>
            <name>
              <surname>Bertolino</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hyde</surname>
              <given-names>TM</given-names>
            </name>
            <name>
              <surname>Shannon-Weickert</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Akil</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Crook</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Vakkalanka</surname>
              <given-names>RK</given-names>
            </name>
            <name>
              <surname>Balkissoon</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Gibbs</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Kleinman</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Weinberger</surname>
              <given-names>DR</given-names>
            </name>
          </person-group>
          <article-title>Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>2004</year>
          <volume>101</volume>
          <fpage>12604</fpage>
          <lpage>12609</lpage>
          <pub-id pub-id-type="pmid">15310849</pub-id>
        </citation>
      </ref>
      <ref id="b13">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Flajolet</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Rakhilin</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Starkova</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Nuangchamnong</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Nairn</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Greengard</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Protein phosphatase 2C binds selectively to and dephosphorylates metabotropic glutamate receptor 3</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>2003</year>
          <volume>100</volume>
          <fpage>16006</fpage>
          <lpage>16011</lpage>
          <pub-id pub-id-type="pmid">14663150</pub-id>
        </citation>
      </ref>
      <ref id="b14">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gegelashvili</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Schousboe</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>High affinity glutamate transporters: Regulation of expression and activity</article-title>
          <source>Mol Pharmacol</source>
          <year>1997</year>
          <volume>52</volume>
          <fpage>6</fpage>
          <lpage>15</lpage>
          <pub-id pub-id-type="pmid">9224806</pub-id>
        </citation>
      </ref>
      <ref id="b15">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gegelashvili</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Civenni</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Racagni</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Danbolt</surname>
              <given-names>NC</given-names>
            </name>
            <name>
              <surname>Schousboe</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Schousboe</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Glutamate receptor agonists up-regulate glutamate transporter GLAST in astrocytes</article-title>
          <source>Neuroreport</source>
          <year>1996</year>
          <volume>8</volume>
          <fpage>261</fpage>
          <lpage>265</lpage>
          <pub-id pub-id-type="pmid">9051792</pub-id>
        </citation>
      </ref>
      <ref id="b16">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gegelashvili</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Dehnes</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Danbolt</surname>
              <given-names>NC</given-names>
            </name>
            <name>
              <surname>Schousboe</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>The high-affinity glutamate transporters GLT1, GLAST, and EAAT4 are regulated via different signalling mechanisms</article-title>
          <source>Neurochem Int</source>
          <year>2000</year>
          <volume>37</volume>
          <fpage>163</fpage>
          <lpage>170</lpage>
          <pub-id pub-id-type="pmid">10812201</pub-id>
        </citation>
      </ref>
      <ref id="b17">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Harrison</surname>
              <given-names>PJ</given-names>
            </name>
          </person-group>
          <article-title>The hippocampus in schizophrenia: A review of the neuropathological evidence and its pathophysiological implications</article-title>
          <source>Psychopharmacology (Berl)</source>
          <year>2004</year>
          <volume>174</volume>
          <fpage>151</fpage>
          <lpage>162</lpage>
          <pub-id pub-id-type="pmid">15205886</pub-id>
        </citation>
      </ref>
      <ref id="b18">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Harrison</surname>
              <given-names>PJ</given-names>
            </name>
          </person-group>
          <article-title>Metabotropic glutamate receptor agonists for schizophrenia</article-title>
          <source>Br J Psychiatry</source>
          <year>2008</year>
          <volume>192</volume>
          <fpage>86</fpage>
          <lpage>87</lpage>
          <pub-id pub-id-type="pmid">18245019</pub-id>
        </citation>
      </ref>
      <ref id="b19">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Harrison</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Weinberger</surname>
              <given-names>DR</given-names>
            </name>
          </person-group>
          <article-title>Schizophrenia genes, gene expression, and neuropathology: On the matter of their convergence</article-title>
          <source>Mol Psychiatry</source>
          <year>2005</year>
          <volume>10</volume>
          <fpage>40</fpage>
          <lpage>68</lpage>
          <pub-id pub-id-type="pmid">15263907</pub-id>
        </citation>
      </ref>
      <ref id="b20">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Harrison</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Lyon</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Sartorius</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Burnet</surname>
              <given-names>PWJ</given-names>
            </name>
            <name>
              <surname>Lane</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>The group II metabotropic glutamate receptor 3 (mGluR3, mGlu3, GRM3): Expression, function, and involvement in schizophrenia</article-title>
          <source>J Psychopharmacol</source>
          <comment>(in press)</comment>
        </citation>
      </ref>
      <ref id="b21">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ingram</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Wiseman</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Tessler</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Emson</surname>
              <given-names>PC</given-names>
            </name>
          </person-group>
          <article-title>Reduction of glial glutamate transporters in the parietal cortex and hippocampus of the EL mouse</article-title>
          <source>J Neurochem</source>
          <year>2001</year>
          <volume>79</volume>
          <fpage>564</fpage>
          <lpage>575</lpage>
          <pub-id pub-id-type="pmid">11701760</pub-id>
        </citation>
      </ref>
      <ref id="b22">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kanai</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Hediger</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>Primary structure and functional characterization of a high-affinity glutamate transporter</article-title>
          <source>Nature</source>
          <year>1992</year>
          <volume>360</volume>
          <fpage>467</fpage>
          <lpage>471</lpage>
          <pub-id pub-id-type="pmid">1280334</pub-id>
        </citation>
      </ref>
      <ref id="b23">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kew</surname>
              <given-names>JNC</given-names>
            </name>
            <name>
              <surname>Pflimlin</surname>
              <given-names>M-C</given-names>
            </name>
            <name>
              <surname>Kemp</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Mutel</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>Differential regulation of synaptic transmission by mGlu2 and mGlu3 at the perforant path inputs to the dentate gyrus and CA1 revealed in mGlu2<sup>&#x2212;/&#x2212;</sup> mice</article-title>
          <source>Neuropharmacology</source>
          <year>2002</year>
          <volume>43</volume>
          <fpage>215</fpage>
          <lpage>221</lpage>
          <pub-id pub-id-type="pmid">12213275</pub-id>
        </citation>
      </ref>
      <ref id="b24">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Konradi</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Heckers</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Molecular aspects of glutamate dysregulation: Implications for schizophrenia and its treatment</article-title>
          <source>Pharmacol Ther</source>
          <year>2003</year>
          <volume>97</volume>
          <fpage>153</fpage>
          <lpage>179</lpage>
          <pub-id pub-id-type="pmid">12559388</pub-id>
        </citation>
      </ref>
      <ref id="b25">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Krystal</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Abi-Saab</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Perry</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>D'souza</surname>
              <given-names>DC</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Gueorguieva</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>McDougall</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Hunsberger</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Belger</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Levine</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Breier</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects</article-title>
          <source>Psychopharmacology (Berl)</source>
          <year>2005</year>
          <volume>179</volume>
          <fpage>303</fpage>
          <lpage>309</lpage>
          <pub-id pub-id-type="pmid">15309376</pub-id>
        </citation>
      </ref>
      <ref id="b26">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Linden</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Baez</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bergeron</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Schoepp</surname>
              <given-names>DD</given-names>
            </name>
          </person-group>
          <article-title>Effects of mGlu2 or mGlu3 receptor deletions on mGlu2/3 receptor agonist (LY354740)-induced brain c-Fos expression: Specific roles for mGlu2 in the amygdala and subcortical nuclei, and mGlu3 in the hippocampus</article-title>
          <source>Neuropharmacology</source>
          <year>2006</year>
          <volume>51</volume>
          <fpage>213</fpage>
          <lpage>228</lpage>
          <pub-id pub-id-type="pmid">16733060</pub-id>
        </citation>
      </ref>
      <ref id="b27">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Linden</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Shannon</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Baez</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Koester</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Schoepp</surname>
              <given-names>DD</given-names>
            </name>
          </person-group>
          <article-title>Anxiolytic-like activity of the mGLU2/3 receptor agonist LY354740 in the elevated plus maze test is disrupted in metabotropic glutamate receptor 2 and 3 knock-out mice</article-title>
          <source>Psychopharmacology (Berl)</source>
          <year>2005</year>
          <volume>179</volume>
          <fpage>284</fpage>
          <lpage>291</lpage>
          <pub-id pub-id-type="pmid">15619115</pub-id>
        </citation>
      </ref>
      <ref id="b28">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Wong</surname>
              <given-names>TP</given-names>
            </name>
            <name>
              <surname>Pozza</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Lingenhoehl</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Sheng</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Auberson</surname>
              <given-names>YP</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>YT</given-names>
            </name>
          </person-group>
          <article-title>Role of NMDA receptor subtypes in governing the direction of hippocampal synaptic plasticity</article-title>
          <source>Science</source>
          <year>2004</year>
          <volume>304</volume>
          <fpage>1021</fpage>
          <lpage>1024</lpage>
          <pub-id pub-id-type="pmid">15143284</pub-id>
        </citation>
      </ref>
      <ref id="b29">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lyon</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Harrison</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Corti</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Burnet</surname>
              <given-names>PWJ</given-names>
            </name>
          </person-group>
          <article-title>Altered expression of glutamate receptors and transporters in metabotropic glutamate receptor 3 (mGluR3; GRM3) knockout mice</article-title>
          <source>J Psychopharmacol</source>
          <year>2006</year>
          <volume>20</volume>
          <fpage>A17</fpage>
          <lpage>A17</lpage>
        </citation>
      </ref>
      <ref id="b30">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lyon</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Harrison</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Corti</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Burnet</surname>
              <given-names>PWJ</given-names>
            </name>
          </person-group>
          <article-title>Altered expression of glutamate receptors and transporters in mGluR2 (GRM2) and mGluR3 (GRM3) knockout mice</article-title>
          <source>Society for Neuroscience</source>
          <year>2007</year>
          <comment>San Diego, USA. Abstract Viewer Program No. 577.14</comment>
        </citation>
      </ref>
      <ref id="b31">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Martin</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Clark</surname>
              <given-names>RE</given-names>
            </name>
          </person-group>
          <article-title>The rodent hippocampus and spatial memory: From synapses to systems</article-title>
          <source>Cell Mol Life Sci</source>
          <year>2007</year>
          <volume>64</volume>
          <fpage>401</fpage>
          <lpage>431</lpage>
          <pub-id pub-id-type="pmid">17256090</pub-id>
        </citation>
      </ref>
      <ref id="b32">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Moghaddam</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Targeting metabotropic glutamate receptors for treatment of the cognitive symptoms of schizophrenia</article-title>
          <source>Psychopharmacology (Berl)</source>
          <year>2004</year>
          <volume>174</volume>
          <fpage>39</fpage>
          <lpage>44</lpage>
          <pub-id pub-id-type="pmid">15205877</pub-id>
        </citation>
      </ref>
      <ref id="b33">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Moghaddam</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Adams</surname>
              <given-names>BW</given-names>
            </name>
          </person-group>
          <article-title>Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats</article-title>
          <source>Science</source>
          <year>1998</year>
          <volume>281</volume>
          <fpage>1349</fpage>
          <lpage>1352</lpage>
          <pub-id pub-id-type="pmid">9721099</pub-id>
        </citation>
      </ref>
      <ref id="b34">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Monyer</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Sprengel</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Schoepfer</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Herb</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Higuchi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lomeli</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Burnashev</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Sakmann</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Seeburg</surname>
              <given-names>PH</given-names>
            </name>
          </person-group>
          <article-title>Heteromeric NMDA receptors: Molecular and functional distinction of subtypes</article-title>
          <source>Science</source>
          <year>1992</year>
          <volume>256</volume>
          <fpage>1217</fpage>
          <lpage>1221</lpage>
          <pub-id pub-id-type="pmid">1350383</pub-id>
        </citation>
      </ref>
      <ref id="b35">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Monyer</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Burnashev</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Laurie</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Sakmann</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Seeburg</surname>
              <given-names>PH</given-names>
            </name>
          </person-group>
          <article-title>Developmental and regional expression in the rat brain and functional properties of four NMDA receptors</article-title>
          <source>Neuron</source>
          <year>1994</year>
          <volume>12</volume>
          <fpage>529</fpage>
          <lpage>540</lpage>
          <pub-id pub-id-type="pmid">7512349</pub-id>
        </citation>
      </ref>
      <ref id="b36">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Morishima</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Miyakawa</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Furuyashiki</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Tanaka</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Mizuma</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Nakanishi</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Enhanced cocaine responsiveness and impaired motor coordination in metabotropic glutamate receptor subtype 2 knockout mice</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>2005</year>
          <volume>102</volume>
          <fpage>4170</fpage>
          <lpage>4175</lpage>
          <pub-id pub-id-type="pmid">15753323</pub-id>
        </citation>
      </ref>
      <ref id="b37">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ohishi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Shigemoto</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Nakanishi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Mizuno</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Distribution of the messenger RNA for a metabotropic glutamate receptor, mGluR2, in the central nervous system of the rat</article-title>
          <source>Neuroscience</source>
          <year>1993a</year>
          <volume>53</volume>
          <fpage>1009</fpage>
          <lpage>1018</lpage>
          <pub-id pub-id-type="pmid">8389425</pub-id>
        </citation>
      </ref>
      <ref id="b38">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ohishi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Shigemoto</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Nakanishi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Mizuno</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Distribution of the mRNA for a metabotropic glutamate receptor (mGluR3) in the rat braAn in situ hybridization study</article-title>
          <source>J Comp Neurol</source>
          <year>1993b</year>
          <volume>335</volume>
          <fpage>252</fpage>
          <lpage>266</lpage>
          <pub-id pub-id-type="pmid">8227517</pub-id>
        </citation>
      </ref>
      <ref id="b39">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Patil</surname>
              <given-names>ST</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Martenyi</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Lowe</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Jackson</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Andreev</surname>
              <given-names>BV</given-names>
            </name>
            <name>
              <surname>Avedisova</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Bardenstein</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Gurovich</surname>
              <given-names>IY</given-names>
            </name>
            <name>
              <surname>Morozova</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Mosolov</surname>
              <given-names>SN</given-names>
            </name>
            <name>
              <surname>Neznanov</surname>
              <given-names>NG</given-names>
            </name>
            <name>
              <surname>Reznik</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Smulevich</surname>
              <given-names>AB</given-names>
            </name>
            <name>
              <surname>Tochilov</surname>
              <given-names>VA</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>BG</given-names>
            </name>
            <name>
              <surname>Monn</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Schoepp</surname>
              <given-names>DD</given-names>
            </name>
          </person-group>
          <article-title>Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: A randomized Phase 2 clinical trial</article-title>
          <source>Nat Med</source>
          <year>2007</year>
          <volume>13</volume>
          <fpage>1102</fpage>
          <lpage>1107</lpage>
          <pub-id pub-id-type="pmid">17767166</pub-id>
        </citation>
      </ref>
      <ref id="b40">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rothstein</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Levey</surname>
              <given-names>AI</given-names>
            </name>
            <name>
              <surname>Dykes-Hoberg</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Jin</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Nash</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Kuncl</surname>
              <given-names>RW</given-names>
            </name>
          </person-group>
          <article-title>Localization of neuronal and glial glutamate transporters</article-title>
          <source>Neuron</source>
          <year>1994</year>
          <volume>13</volume>
          <fpage>713</fpage>
          <lpage>725</lpage>
          <pub-id pub-id-type="pmid">7917301</pub-id>
        </citation>
      </ref>
      <ref id="b41">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sartorius</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>Nagappan</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Lipska</surname>
              <given-names>BK</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Sei</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Ren-Patterson</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Weinberger</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>Harrison</surname>
              <given-names>PJ</given-names>
            </name>
          </person-group>
          <article-title>Alternative splicing of human metabotropic glutamate receptor 3</article-title>
          <source>J Neurochem</source>
          <year>2006</year>
          <volume>96</volume>
          <fpage>1139</fpage>
          <lpage>1148</lpage>
          <pub-id pub-id-type="pmid">16417579</pub-id>
        </citation>
      </ref>
      <ref id="b42">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sartorius</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>Weinberger</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>Hyde</surname>
              <given-names>TM</given-names>
            </name>
            <name>
              <surname>Harrison</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Kleinman</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Lipska</surname>
              <given-names>BK</given-names>
            </name>
          </person-group>
          <article-title>Expression of a GRM3 splice variant is increased in the dorsolateral prefrontal cortex of individuals carrying a schizophrenia risk SNP</article-title>
          <source>Neuropsychopharmacology</source>
          <year>2008</year>
          <comment>
            <ext-link ext-link-type="doi" xlink:href="10.1038/sj.npp.1301669">10.1038/sj.npp.1301669</ext-link>
          </comment>
        </citation>
      </ref>
      <ref id="b43">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schmitt</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Asan</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Puschel</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Kugler</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Cellular and regional distribution of the glutamate transporter GLAST in the CNS of rats: Nonradioactive in situ hybridization and comparative immunocytochemistry</article-title>
          <source>J Neurosci</source>
          <year>1997</year>
          <volume>17</volume>
          <fpage>1</fpage>
          <lpage>10</lpage>
          <pub-id pub-id-type="pmid">8987731</pub-id>
        </citation>
      </ref>
      <ref id="b44">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sheng</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>SH</given-names>
            </name>
          </person-group>
          <article-title>Growth of the NMDA receptor industrial complex</article-title>
          <source>Nat Neurosci</source>
          <year>2000</year>
          <volume>3</volume>
          <fpage>633</fpage>
          <lpage>635</lpage>
          <pub-id pub-id-type="pmid">10862688</pub-id>
        </citation>
      </ref>
      <ref id="b45">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shigemoto</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Kinoshita</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Wada</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Nomura</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ohishi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Takada</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Flor</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Neki</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Abe</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Nakanishi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Mizuno</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Differential presynaptic localization of metabotropic glutamate receptor subtypes in the rat hippocampus</article-title>
          <source>J Neurosci</source>
          <year>1997</year>
          <volume>17</volume>
          <fpage>7503</fpage>
          <lpage>7522</lpage>
          <pub-id pub-id-type="pmid">9295396</pub-id>
        </citation>
      </ref>
      <ref id="b46">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shigeri</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Seal</surname>
              <given-names>RP</given-names>
            </name>
            <name>
              <surname>Shimamoto</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Molecular pharmacology of glutamate transporters, EAATs and VGLUTs</article-title>
          <source>Brain Res Brain Res Rev</source>
          <year>2004</year>
          <volume>45</volume>
          <fpage>250</fpage>
          <lpage>265</lpage>
          <pub-id pub-id-type="pmid">15210307</pub-id>
        </citation>
      </ref>
      <ref id="b47">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Swanson</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Bures</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Linden</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Monn</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Schoepp</surname>
              <given-names>DD</given-names>
            </name>
          </person-group>
          <article-title>Metabotropic glutamate receptors as novel targets for anxiety and stress disorders</article-title>
          <source>Nat Rev Drug Discov</source>
          <year>2005</year>
          <volume>4</volume>
          <fpage>131</fpage>
          <lpage>144</lpage>
          <pub-id pub-id-type="pmid">15665858</pub-id>
        </citation>
      </ref>
      <ref id="b48">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sweatt</surname>
              <given-names>JD</given-names>
            </name>
          </person-group>
          <article-title>Hippocampal function in cognition</article-title>
          <source>Psychopharmacology (Berl)</source>
          <year>2004</year>
          <volume>174</volume>
          <fpage>99</fpage>
          <lpage>110</lpage>
          <pub-id pub-id-type="pmid">15205881</pub-id>
        </citation>
      </ref>
      <ref id="b49">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tamaru</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Nomura</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Mizuno</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Shigemoto</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Distribution of metabotropic glutamate receptor mGluR3 in the mouse CNS: Differential location relative to pre- and post-synaptic sites</article-title>
          <source>Neuroscience</source>
          <year>2001</year>
          <volume>106</volume>
          <fpage>481</fpage>
          <lpage>503</lpage>
          <pub-id pub-id-type="pmid">11591452</pub-id>
        </citation>
      </ref>
      <ref id="b50">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tan</surname>
              <given-names>HY</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Sust</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Buckholtz</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Meyers</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Egan</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Mattay</surname>
              <given-names>VS</given-names>
            </name>
            <name>
              <surname>Meyer-Lindenberg</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Weinberger</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>Callicott</surname>
              <given-names>JH</given-names>
            </name>
          </person-group>
          <article-title>Epistasis between catechol-<italic>O</italic>-methyltransferase and type II metabotropic glutamate receptor 3 genes on working memory brain function</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>2007</year>
          <volume>104</volume>
          <fpage>12536</fpage>
          <lpage>12541</lpage>
          <pub-id pub-id-type="pmid">17636131</pub-id>
        </citation>
      </ref>
      <ref id="b51">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tian</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Lai</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Guo</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Butchbach</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>CL</given-names>
            </name>
          </person-group>
          <article-title>Translational control of glial glutamate transporter EAAT2 expression</article-title>
          <source>J Biol Chem</source>
          <year>2007</year>
          <volume>282</volume>
          <fpage>1727</fpage>
          <lpage>1737</lpage>
          <pub-id pub-id-type="pmid">17138558</pub-id>
        </citation>
      </ref>
      <ref id="b52">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tyszkiewicz</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Gu</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Cai</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Yan</surname>
              <given-names>Z</given-names>
            </name>
          </person-group>
          <article-title>Group II metabotropic glutamate receptors enhance NMDA receptor currents via a protein kinase C-dependent mechanism in pyramidal neurones of rat prefrontal cortex</article-title>
          <source>J Physiol</source>
          <year>2004</year>
          <volume>554</volume>
          <issue>Part 3</issue>
          <fpage>765</fpage>
          <lpage>777</lpage>
          <pub-id pub-id-type="pmid">14645456</pub-id>
        </citation>
      </ref>
      <ref id="b53">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wroblewska</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Santi</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Neale</surname>
              <given-names>JH</given-names>
            </name>
          </person-group>
          <article-title><italic>N</italic>-acetylaspartylglutamate activates cyclic AMP-coupled metabotropic glutamate receptors in cerebellar astrocytes</article-title>
          <source>Glia</source>
          <year>1998</year>
          <volume>24</volume>
          <fpage>172</fpage>
          <lpage>179</lpage>
          <pub-id pub-id-type="pmid">9728763</pub-id>
        </citation>
      </ref>
      <ref id="b54">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yokoi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kobayashi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Manabe</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Takahashi</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Sakaguchi</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Katsuura</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Shigemoto</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Ohishi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Nomura</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Nakamura</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Nakao</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Katsuki</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nakanishi</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Impairment of hippocampal mossy fiber LTD in mice lacking mGluR2</article-title>
          <source>Science</source>
          <year>1996</year>
          <volume>273</volume>
          <fpage>645</fpage>
          <lpage>647</lpage>
          <pub-id pub-id-type="pmid">8662555</pub-id>
        </citation>
      </ref>
    </ref-list>
  </back>
</article>
